WASHINGTON ( November 26) -- Yesterday, the Trump administration announced Maximum Fair Prices (MFPs) for the next 15 Medicare Part D drugs selected for price setting under the Medicare Drug Price Negotiation Program. The new prices take effect in January 2027.   Incubate's executive director, John Stanford, issued the following statement in response to the announcement:   " Today's announcement is another reminder of the fundamental flaws in existing federal drug-pricing p

Incubate, a coalition of life sciences investors, today unveiled the   Life Sciences Rare Disease Tracker , a tool designed to measure...

On the latest episode  of the Making Medicine podcast, Incubate executive director John Stanford sat down with Thomas Kaiser of Avicenna...

In a new executive order , President Trump called on HHS Secretary Robert F. Kennedy Jr. to work with Congress to end the "pill penalty" -- a provision in Medicare's drug pricing program that discourages investment in small molecule drugs. Ever since the Inflation Reduction Act was introduced, Incubate has worked to educate the public and policymakers alike about the detrimental impacts of the pill penalty  on life sciences research and development. An Incubate survey found 8

Incubate executive director John Stanford was recently featured in a PharmaVoice  article by reporter Amy Baxter on proposed reforms to...

BioWorld  regulatory editor Mari Serebrov recently interviewed Incubate's executive director John Stanford for her article on how the...

Incubate executive director John Stanford was recently featured in an Endpoints News  article by senior editor Zachary Brennan on...

WASHINGTON, D.C. (March 5, 2025) -- This week, Senators Thom Tillis (R-NC), Ted Budd (R-NC), Marsha Blackburn (R-TN), James Lankford...

STAT reporter Ed Silverman recently interviewed Incubate's execute director John Stanford for an article  on the EPIC Act's...

WASHINGTON (January 17)  -- Today, the Centers for Medicare & Medicaid Services announced the second round of Medicare Part D drugs...

WASHINGTON ( January 13 ) -- Today, Incubate Policy Lab released insights  from a survey of life sciences venture capital investors about...

August was a momentous month for the life sciences ecosystem, and September looks to be just as significant. In this blog post, we want...

WASHINGTON (August 15)  -- Today, the Biden administration announced Maximum Fair Prices (MFPs) for the first 10 drugs selected for...

WASHINGTON (June 13) -- Today, Incubate launched the Life Science Investment Tracker, a database monitoring changes in investment,...

Incubate is an international coalition of life science venture capitalists committed to educating policymakers on the role of venture...